Latest News & Features
Big Pharma
The EU General Court today rejected a trademark appeal brought by Swiss pharmaceutical company Novartis. 25 September 2018
Americas
The UK government has today confirmed that a “winter fact-finding mission” will soon be carried out by UK life sciences experts in Texas, building on the science and technology cooperation agreement signed by the UK and the US last year. 24 September 2018
Americas
US-based Allergan and the Saint Regis Mohawk Tribe have accused pharmaceutical company Amneal of infringing two patents in its generic version of an eye treatment. 24 September 2018
Asia-Pacific
The Australian Competition & Consumer Commission announced yesterday that it has approved the merger of generic drugs companies Arrow and Apotex. 21 September 2018
Europe
The English High Court has ruled that Gilead’s drug Truvada is not entitled to a supplementary protection certificate because it failed to meet the standards set out by Europe’s highest court earlier this year. 20 September 2018
Americas
ERS Genomics and the Broad Institute of MIT and Harvard signed CRISPR licensing deals with Thermo Fisher Scientific on Tuesday, shortly before ERS expanded a separate agreement with Oxford Genetics. 20 September 2018
Americas
Gene-editing company CRISPR Therapeutics has partnered with regenerative medicine-focused ViaCyte to focus on diabetes treatments. 19 September 2018
Big Pharma
Researchers from three London universities and the Francis Crick Institute have joined together to form a hub for cancer biotherapeutics research and treatment, made possible by a £14 million investment from charity Cancer Research UK. 19 September 2018
Americas
The US Court of Appeals for the Federal Circuit yesterday overturned a Patent Trial and Appeal Board decision that had said chemical company DuPont hadn’t proved that a patent was invalid. 18 September 2018
Americas
Allergan has revealed plans to buy Bonti, a biotechnology company focused on medical aesthetics, for $195 million. 18 September 2018